Knee Pain Relief: New Electronic Sleeve Offers Hope to Sufferers
University of Southampton innovation uses gentle electrical pulses to enhance mobility
A groundbreaking electronic knee sleeve developed by researchers at the University of Southampton is showing significant promise in alleviating pain and increasing walking distance for individuals suffering from osteoarthritis.
Innovative Wearable Technology
This innovative wearable device employs transcutaneous electrical nerve stimulation (TENS) to target knee discomfort. Electrodes integrated into the sleeve deliver controlled electrical pulses to the knee area, managed by an electronic control unit.
The project is backed by funding from the Medical Research Council.
Participant Experiences Boost Confidence
Early results from a 12-week clinical trial are highly encouraging. Participants are using the device for up to one hour daily, five to seven days a week.
“The response from participants has been fantastic, with most reporting that it is helping to reduce pain and stiffness, enabling them to do more activities. The device is also comfortable to wear and easy to use.”
—Prof Kai Yang, Lead Researcher
Mike Coyne, 58, who is awaiting a knee replacement due to eight years of osteoarthritis, shared his positive experience. He noted, With the sleeve on, I can walk a lot further and a lot quicker, without limping.
Mike added that the sleeve has transformed his daily routine. It’s really helped me when it comes to taking my dog Charlie for a walk – taking him out is now enjoyable exercise rather than a painful chore. With the sleeve, I can get a bit of exercise – it’s improved my overall health.
Addressing Widespread Osteoarthritis
Knee osteoarthritis, a condition causing pain and stiffness in the joints, affects an estimated five million people in the UK alone, highlighting the broad potential impact of this new technology. The NHS reports that over 10 million people in the UK have a hip or knee problem.
The research team aims to enroll 80 participants aged 45 to 75 who have been diagnosed with knee osteoarthritis into the ongoing trial.
